You have 9 free searches left this month | for more free features.

Graves' orbitopathy

Showing 26 - 50 of 159

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glucocorticoids and Bone in Graves' Ophthalmopathy

Active, not recruiting
  • Graves Ophthalmopathy
  • Aarhus C, Central Denmark Region, Denmark
  • +1 more
Feb 21, 2022

Graves Ophthalmopathy Trial in São Paulo (Orbital decompression)

Completed
  • Graves Ophthalmopathy
  • Orbital decompression
  • São Paulo, Brazil
    University of Sao Paulo General Hospital
Aug 11, 2019

Thyroid Eye Disease, Graves' Orbitopathy Trial in United States (Teprotumumab)

Approved for marketing
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Beverly Hills, California
  • +7 more
Mar 13, 2020

Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

Not yet recruiting
  • Thyroid Eye Disease
  • VRDN-001 10 mg/kg Drug:
  • (no location specified)
Sep 7, 2023

Graves Disease Trial in Hong Kong (Echopulse)

Completed
  • Graves Disease
  • Echopulse
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 17, 2022

Thyroid Eye Disease Trial in United States (VRDN-001, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Beverly Hills, California
  • +16 more
Aug 11, 2022

Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

Not yet recruiting
  • Thyroid-Associated Ophthalmopathy
  • (no location specified)
Mar 18, 2022

Exophthalmos, Orbitopathy, Graves, Surgery Trial (Orbital decompression with ultrasonic bone removal)

Completed
  • Exophthalmos
  • +2 more
  • Orbital decompression with ultrasonic bone removal
  • (no location specified)
Jul 18, 2019

Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)

Withdrawn
  • Thyroid Associated Ophthalmopathies
  • Sodium selenate
  • Sugar pill
  • (no location specified)
Aug 12, 2021

Thyroid Eye Disease Trial in Beijing (ZB001 for injection)

Not yet recruiting
  • Thyroid Eye Disease
  • ZB001 for injection
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Mar 7, 2023

Graves' Ophthalmopathy Trial in Canada (RVT-1401)

Completed
  • Graves' Ophthalmopathy
  • Vancouver, British Columbia, Canada
  • +3 more
Dec 24, 2021

Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral

Active, not recruiting
  • Ophthalmopathy, Thyroid-Associated
  • Gothenburg, Sweden
  • +4 more
Sep 17, 2021

Thyroid Eye Disease Trial (peri-levator betamethasone injection, peri-levator triamcinolone injection, peri-levator and

Not yet recruiting
  • Thyroid Eye Disease
  • peri-levator betamethasone injection
  • +3 more
  • (no location specified)
Jul 15, 2021

Thyroid Eye Disease Trial in Los Angeles (Hyaluronic Acid Gel injection, Saline injection)

Terminated
  • Thyroid Eye Disease
  • Hyaluronic Acid Gel injection
  • Saline injection
  • Los Angeles, California
  • +1 more
Sep 27, 2021

Thyroid Orbitopathy Trial (Selenium, Placebo)

Completed
  • Thyroid Orbitopathy
  • Selenium
  • Placebo
  • (no location specified)
Mar 25, 2019

Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

Recruiting
  • Graves Ophthalmopathy
  • +8 more
  • Doxycycline hyclate
  • Placebo
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Nov 16, 2021

Graves' Ophthalmopathy (GO) Trial in Worldwide (RVT-1401 (Administered via subcutaneous injection), Placebo (Administered via

Terminated
  • Graves' Ophthalmopathy (GO)
  • RVT-1401 (Administered via subcutaneous injection)
  • Placebo (Administered via subcutaneous injection)
  • Beverly Hills, California
  • +24 more
Aug 26, 2022

mDixon TSE MRI Sequence And Conventional MRI Sequences In

Completed
  • Dysthyroid Ophthalmopathies
    • Paris, Ile De France, France
      Fondation Ophtalmologique Adolphe de Rothschild
    May 26, 2021

    Anti-insulin-like Growth Factor-1 Receptor Antibodies in Graves'

    Completed
    • Graves Ophthalmopathy
    • +2 more
    • Serum antibodies against the IGF-1R
    • Pisa, Italy
      Endocrinology Unit I, University of Pisa
    Jul 26, 2018

    Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

    Recruiting
    • Thyroid Eye Disease
    • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
    • +2 more
    • Boston, Massachusetts
      Mass Eye and Ear
    Feb 8, 2022

    Graves Disease, Graves Ophthalmopathy, Liver Diseases Trial (every week IVMP therapy, very high doses IVMP therapy)

    Completed
    • Graves Disease
    • +13 more
    • every week IVMP therapy
    • very high doses IVMP therapy
    • (no location specified)
    Sep 11, 2018

    The Effect of Thyroid Hormon Levels on the Corneal Measures

    Completed
    • Thyroid Disorder
    • Corneal Opacity
      • Diyarbakır, Turkey
        Sağlık Bilimleri Üniversitesi Gazi Yaşargil Training and Researc
      Feb 12, 2021

      Blood Pressure

      Completed
      • Graves Disease
      • +4 more
      • (no location specified)
      Jul 17, 2018

      Exophthalmos, Graves Ophthalmopathy, Orbital Tumor Trial in Zurich (Exophthalmos measurement)

      Recruiting
      • Exophthalmos
      • +3 more
      • Exophthalmos measurement
      • Zurich, Switzerland
        Ophthalmology Department, University Hospital Zurich
      Jan 10, 2021

      Coagulation After Intravenous Methylprednisolone Administration

      Completed
      • Graves' Disease
      • +3 more
      • (no location specified)
      May 12, 2018